Sarah S. Donaldson

Q: What Schools Are Affiliated With Sarah S. Donaldson

Sarah S. Donaldson is affiliated with the following schools: Washington University in St. Louis, University at Buffalo, University of Oregon, Stanford University, University of Washington, University of California, San Francisco, University of Nebraska Medical Center, Harvard University

Sarah S. Donaldson's AcademicInfluence.com Rankings

Sarah S. Donaldson

Medical

#1823

World Rank

#2200

Historical Rank

#425

USA Rank

Oncology

#96

World Rank

#100

Historical Rank

#19

USA Rank

medical Degrees

Download Badge

Medical

Sarah S. Donaldson's Degrees

Doctorate Medicine Harvard University
PhD Radiation Biology Stanford University

Why Is Sarah S. Donaldson Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Sarah S. Donaldson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. (2003) (1127)
The Third Intergroup Rhabdomyosarcoma Study. (1995) (901)
Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. (2001) (888)
Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort (2009) (790)
Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. (2001) (696)
The intergroup rhabdomyosarcoma study‐II (1993) (677)
Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. (2002) (657)
Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. (2010) (589)
The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research. (2009) (548)
New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. (2006) (506)
Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. (2009) (467)
Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. (2009) (453)
Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study. (2009) (441)
Cardiac disease following treatment of Hodgkin's disease in children and adolescents. (1993) (426)
Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV. (2003) (398)
Rhabdomyosarcoma and Undifferentiated Sarcoma in the First Two Decades of Life: A Selective Review of Intergroup Rhabdomyosarcoma Study Group Experience and Rationale for Intergroup Rhabdomyosarcoma Study V (2001) (353)
Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. (2002) (339)
Fertility of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. (2010) (317)
Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. (2003) (310)
Neurocognitive status in long-term survivors of childhood CNS malignancies: a report from the Childhood Cancer Survivor Study. (2009) (295)
Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803. (2009) (278)
The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: A report from the childhood cancer survivor study (2014) (269)
Second cancers following pediatric Hodgkin's disease. (1998) (254)
Risk of Second Primary Thyroid Cancer after Radiotherapy for a Childhood Cancer in a Large Cohort Study: An Update from the Childhood Cancer Survivor Study (2010) (236)
Advances toward an understanding of brainstem gliomas. (2006) (233)
Supervoltage orbital radiotherapy for Graves' ophthalmopathy. (1973) (230)
Radiation dose and breast cancer risk in the childhood cancer survivor study. (2009) (229)
The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment Protocols (2001) (223)
Stroke as a late treatment effect of Hodgkin's Disease: a report from the Childhood Cancer Survivor Study. (2005) (222)
Thyroid dysfunction after radiotherapy in children with Hodgkin's disease (1980) (214)
Epithelioid granulomas associated with Hodgkin's disease. Clinical correlations in 55 previously untreated patients (1978) (212)
Profile of daily life in children with brain tumors: an assessment of health-related quality of life. (2005) (208)
Female survivors of childhood cancer: preterm birth and low birth weight among their children. (2006) (207)
Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort. (2016) (204)
Rhabdomyosarcoma of head and neck in children (1973) (202)
Isolated granulomas in Hodgkin's disease. (1970) (201)
Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience. (1990) (194)
Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG. (2001) (191)
A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group. (1998) (188)
Optimization of importance factors in inverse planning. (1999) (184)
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study. (2004) (180)
Treatment of children and young adults with early-stage non-Hodgkin's lymphoma. (1997) (173)
Role of beam orientation optimization in intensity-modulated radiation therapy. (2001) (172)
Alterations of nutritional status. Impact of chemotherapy and radiation therapy (1979) (170)
Adriamycin Activating a Recall Phenomenon After Radiation Therapy (1974) (165)
Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III (1999) (164)
Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy. (2010) (161)
Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease. (1987) (160)
Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology Group. (2007) (158)
Appearance of Graves' disease on orbital computed tomography. (1979) (156)
A study of the nutritional status of pediatric cancer patients. (1981) (152)
Medical care in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. (2008) (148)
Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort. (2018) (141)
Complications of treatment of Hodgkin's disease in children. (1982) (141)
ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience. (1994) (139)
Prognostic factors in the radiotherapy of Graves' ophthalmopathy. (1990) (133)
Nutritional consequences of radiotherapy. (1977) (132)
High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillance. (2009) (130)
What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract? (2001) (127)
Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group. (2006) (127)
GENETIC EFFECTS OF RADIOTHERAPY FOR CHILDHOOD CANCER (2003) (126)
Radiation enteritis in children. A retrospective review, clinicopathologic correlation, and dietary management (1975) (124)
Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: A report from the Children's Oncology Group (2015) (122)
Primary radiotherapy for localized orbital MALT lymphoma. (2002) (120)
Special nutritional needs of children with malignancies: a review. (1990) (115)
Results of treatment of childhood localized non-Hodgkin's lymphoma with combination chemotherapy with or without radiotherapy. (1990) (114)
Thyroid Cancer in Childhood Cancer Survivors: A Detailed Evaluation of Radiation Dose Response and its Modifiers (2006) (113)
Pregnancy following oophoropexy and total nodal irradiation in women with Hodgkinapos;s disease (1976) (112)
Radiotherapy is successful treatment for orbital lymphoma. (1993) (111)
Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy. (2003) (108)
Response of growing bone to irradiation: a proposed late effects scoring system. (1995) (108)
Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997. (2002) (107)
Pregnancy outcome of partners of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. (2003) (107)
Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy. (1989) (106)
VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial. (2002) (106)
Visual results and ocular complications following radiotherapy for retinoblastoma. (1978) (104)
Nasopharyngeal carcinoma in the young: a combined M.D. Anderson and Stanford experience. (1990) (103)
Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma? (2001) (102)
Does bladder preservation (as a surgical principle) lead to retaining bladder function in bladder/prostate rhabdomyosarcoma? Results from intergroup rhabdomyosarcoma study iv. (2004) (101)
Radiation-Related New Primary Solid Cancers in the Childhood Cancer Survivor Study: Comparative Radiation Dose Response and Modification of Treatment Effects. (2016) (99)
Primary and metastatic rhabdomyosarcoma in the breast: neoplasms of adolescent females, a report from the Intergroup Rhabdomyosarcoma Study. (1997) (98)
Genetic effects of radiotherapy for childhood cancer: gonadal dose reconstruction. (2004) (98)
Chemotherapy and Thyroid Cancer Risk: A Report from the Childhood Cancer Survivor Study (2011) (96)
Low-dose radiation therapy (2 Gy × 2) in the treatment of orbital lymphoma. (2013) (94)
Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group. (2018) (94)
Medulloblastoma: freedom from relapse longer than 8 years--a therapeutic cure? (1991) (93)
Pediatric Hodgkin's disease. II. Results of therapy (1976) (93)
Management of the pregnant patient with Hodgkin's disease. (1981) (92)
Quality of life outcomes in proton and photon treated pediatric brain tumor survivors. (2014) (91)
Dosimetric effects of patient displacement and collimator and gantry angle misalignment on intensity modulated radiation therapy. (2000) (90)
Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III. (1999) (90)
Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. (2007) (90)
Malignant astrocytoma following radiotherapy of a craniopharyngoima. Case report. (1978) (89)
Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV. (2004) (89)
Bacterial infections in pediatric Hodgkin's disease. Relationship to radiotherapy, chemotherapy and splenectomy (1978) (88)
Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: Evaluation of increasing the dose intensity of chemotherapy—a report from the Children's Oncology Group (2007) (86)
Radiation induced height impairment in pediatric Hodgkin's disease. (1994) (85)
Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group. (2011) (84)
Radiation therapy for intracranial germ cell tumors. (2003) (84)
Long-term results of irradiation for patients with progressive Graves' ophthalmopathy. (2001) (83)
Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma. (2012) (82)
Long‐term medical effects of childhood and adolescent rhabdomyosarcoma: A report from the childhood cancer survivor study (2005) (81)
Endodermal sinus tumor. The stanford experience and the first reported case arising in the vulva (1978) (80)
Risk factors for obesity in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. (2012) (78)
Randomized phase II window trial of two schedules of irinotecan with vincristine in patients with first relapse or progression of rhabdomyosarcoma: a report from the Children's Oncology Group. (2010) (78)
High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin's disease: results and prognostic indices. (2004) (77)
Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. (2007) (75)
Ewing sarcoma: Radiation dose and target volume (2004) (75)
Hodgkin's disease. (1987) (75)
Radiotherapy of lymphoid diseases of the orbit. (1984) (74)
Treatment of unfavorable childhood Hodgkin's disease with VEPA and low-dose, involved-field radiation. (2002) (72)
Herpes zoster and varicella infections in children with hodgkin's disease. An analysis of contributing factors (1978) (72)
Ifosfamide and Etoposide Are Superior to Vincristine and Melphalan for Pediatric Metastatic Rhabdomyosarcoma When Administered With Irradiation and Combination Chemotherapy: A Report From the Intergroup Rhabdomyosarcoma Study Group (2001) (72)
Radiation therapy for rhabdomyosarcoma: local failure risk for Clinical Group III patients on Intergroup Rhabdomyosarcoma Study II. (1997) (70)
Retroperitoneal node biopsy in paratesticular rhabdomyosarcoma. (1994) (70)
Significance and management of computed tomography detected pulmonary nodules: a report from the National Wilms Tumor Study Group. (1999) (69)
Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IV. (2003) (68)
Rhabdomyosarcoma: many similarities, a few philosophical differences. (2005) (68)
Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report. (1994) (68)
Non‐Hodgkin's lymphomas. VI. Results of treatment in childhood (1974) (68)
Rhabdomyosarcoma in infants younger than 1 year (2011) (68)
An attempt to use a common staging system in rhabdomyosarcoma: a report of an international workshop initiated by the International Society of Pediatric Oncology (SIOP). (1989) (68)
Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study. (2004) (67)
Characterization of postsplenectomy bacteremia among patients with and without lymphoma. (1972) (67)
Posterior ocular abnormalities after irradiation for retinoblastoma: a histopathological study. (1980) (65)
Radiation therapy for benign disease of the orbit. (1999) (65)
Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease. (2004) (65)
The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects. (1999) (63)
Current concepts in cancer: effects of cancer and cancer treatment on the nutrition of the host. (1979) (62)
Nutritional support as an adjunct to radiation therapy. (1984) (61)
Late relapse among patients treated for Hodgkin's disease. (1985) (60)
External beam radiation therapy enhances local control in pigmented villonodular synovitis. (2009) (60)
Treatment results among adults with childhood tumors: a 20-year experience. (1989) (60)
Aggressive management of second primary tumors in survivors of hereditary retinoblastoma. (1989) (60)
Computed tomography in orbital pseudothumor (idiopathic orbital inflammation). (1976) (58)
Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group. (2001) (57)
Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease. (1993) (57)
Treatment of localized primary non-Hodgkin's lymphoma of bone in children: a Pediatric Oncology Group study. (1999) (57)
Local control and outcome in children with localized vaginal rhabdomyosarcoma: A report from the Soft Tissue Sarcoma committee of the Children's Oncology Group (2011) (57)
Diffuse small noncleaved cell lymphoma in children, Burkitt's versus non‐Burkitt's types. Results from the pediatric oncology group and st. jude children's research hospital (1989) (56)
Venoocclusive disease of the liver after chemotherapy with vincristine, actinomycin D, and cyclophosphamide for the treatment of rhabdomyosarcoma (1997) (55)
Effect of radiotherapy techniques (IMRT vs. 3D-CRT) on outcome in patients with intermediate-risk rhabdomyosarcoma enrolled in COG D9803--a report from the Children's Oncology Group. (2012) (54)
Late events occurring five years or more after successful therapy for childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. (2004) (54)
A prospective randomized clinical trial of total parenteral nutrition in children with cancer. (1982) (54)
Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 study. (2012) (54)
Treatment of orbital pseudotumor (idiopathic orbital inflammation) by radiation therapy. (1980) (54)
Childhood Cancer: Patterns of Protocol Participation in a National Survey (2001) (53)
Hyperfractionated radiation in children with rhabdomyosarcoma--results of an Intergroup Rhabdomyosarcoma Pilot Study. (1995) (53)
A feasibility, toxicity, and early response study of etoposide, ifosfamide, and vincristine for the treatment of children with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS) IV pilot study. (1997) (51)
High-dose therapy and autologous hematopoietic cell transplantation in children with primary refractory and relapsed Hodgkin's disease: atopy predicts idiopathic diffuse lung injury syndromes. (2001) (50)
Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children's Oncology Group. (2015) (49)
The value of adjuvant chemotherapy in the management of sarcomas in children (1985) (47)
Combined modality therapy in malignant lymphomas. (1977) (46)
Retinoblastoma: biology, presentation, and current management. (1989) (46)
Characteristics and outcomes of rhabdomyosarcoma patients with isolated lung metastases from IRS-IV. (2005) (46)
Absolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer. (2013) (45)
Langerhans' cell histiocytosis of the head and neck (1987) (45)
Increased local failure for patients with intermediate‐risk rhabdomyosarcoma on ARST0531: A report from the Children's Oncology Group (2019) (45)
Cyclophosphamide Dose Intensification during Induction Therapy for Intermediate-Risk Pediatric Rhabdomyosarcoma Is Feasible but Does Not Improve Outcome (2004) (45)
Rhabdomyosarcoma: the Stanford experience using a TNM staging system. (1986) (44)
Intra-arterial infusion of radiosensitizer (BUdR) combined with hypofractionated irradiation and chemotherapy for primary treatment of osteogenic sarcoma. (1985) (44)
Second cancers after Hodgkin's disease in childhood. (1996) (44)
Radiation Therapy of Benign Diseases (1990) (43)
Hodgkin's disease in the very young. (1994) (43)
Treatment of pediatric Hodgkin's lymphoma. (1999) (43)
Decreased fertility among female childhood cancer survivors who received 22-27 Gy hypothalamic/pituitary irradiation: a report from the Childhood Cancer Survivor Study. (2011) (40)
Parameningeal rhabdomyosarcoma: results of an international workshop. (1996) (40)
Delayed primary excision with subsequent modification of radiotherapy dose for intermediate‐risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee (2015) (40)
Longitudinal follow‐up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study (2017) (39)
Risk of salivary gland cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. (2013) (39)
Staging of Hodgkin disease in children: comparison of CT and lymphography with laparotomy. (1990) (39)
Lessons from our children. (1993) (38)
Case study: suprasellar germinoma presenting with psychotic and obsessive-compulsive symptoms. (2000) (38)
Pulmonary outcomes in survivors of childhood central nervous system malignancies: A report from the childhood cancer survivor study (2014) (36)
Changes in health status among aging survivors of pediatric upper and lower extremity sarcoma: a report from the childhood cancer survivor study. (2013) (36)
Pregnancy following oophoropexy and total nodal irradiation in women with Hodgkin's disease. (1977) (36)
Radiation-induced premature menopause: a misconception. (1995) (36)
Influence of noncompliance with radiation therapy protocol guidelines and operative bed recurrences for children with rhabdomyosarcoma and microscopic residual disease: a report from the Children's Oncology Group. (2011) (35)
Regional nodal involvement and patterns of spread along in-transit pathways in children with rhabdomyosarcoma of the extremity: a report from the Children's Oncology Group. (2011) (35)
Second cancers in long-term survivors of Ewing's sarcoma. (1992) (35)
Radiation-induced inhibition of compensatory renal growth in the weanling mouse kidney. (1978) (34)
In vivo effects of horse and rabbit antithymocyte globulin in patients with severe aplastic anemia (2014) (34)
Astrocytoma in children: 14 years' experience at Stanford University Medical Center. (1988) (33)
The effect of radiation timing on patients with high-risk features of parameningeal rhabdomyosarcoma: an analysis of IRS-IV and D9803. (2013) (32)
Rhabdomyosarcoma: contemporary status and future directions. The Lucy Wortham James Clinical Research Award. (1989) (32)
Results of treatment of fifty‐six patients with localized retroperitoneal and pelvic rhabdomyosarcoma: A report from The Intergroup Rhabdomyosarcoma Study‐IV, 1991–1997 (2004) (30)
Response to pneumococcal vaccine among children with Hodgkin's disease. (1981) (29)
Continuing Medical Student Education During the Coronavirus Disease 2019 (COVID-19) Pandemic: Development of a Virtual Radiation Oncology Clerkship (2020) (29)
Postirradiation sarcoma in retinoblastoma. Induction or predisposition? (1988) (29)
Treatment Approach and Outcomes in Infants With Localized Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group. (2019) (29)
The Children's Oncology Group Radiation Oncology Discipline: 15 Years of Contributions to the Treatment of Childhood Cancer. (2018) (28)
Does debulking improve survival rate in advanced-stage retroperitoneal embryonal rhabdomyosarcoma? (1999) (28)
Treatment of Pediatric Hodgkin Lymphoma (2008) (28)
Management of children with metastatic spinal myxopapillary ependymoma using craniospinal irradiation. (2000) (27)
Effect of nutritional status on response to therapy. (1982) (27)
Relapse after treatment of pediatric hodgkin lymphoma: Outcome and role of surveillance after end of therapy (2013) (26)
Rhabdomyosarcoma of the parotid region occurring in childhood and adolescence (2001) (26)
Electrophysiologic evidence of subclinical injury to the posterior columns of the human spinal cord after therapeutic radiation (1982) (26)
Histologic subtypes of breast cancer following radiotherapy for Hodgkin lymphoma. (2014) (26)
Vincristine, dactinomycin, cyclophosphamide (VAC) versus VAC/V plus irinotecan (VI) for intermediate-risk rhabdomyosarcoma (IRRMS): A report from the Children’s Oncology Group Soft Tissue Sarcoma Committee. (2014) (26)
John Caffey Award: chemotherapy-induced inhibition of compensatory renal growth in the immature mouse. (1980) (26)
Early treatment failure in intermediate-risk rhabdomyosarcoma: results from IRS-IV and D9803--a report from the Children's Oncology Group. (2010) (25)
Results in patients with cranial parameningeal sarcoma and metastases (Stage 4) treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols II–IV, 1978–1997: Report from the Children's Oncology Group (2008) (24)
Supervoltage orbital radiotherapy for progressive Graves' ophthalmopathy: Results of a twenty-year experience (1989) (24)
45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy (2017) (24)
Topography of childhood tumors: pediatric coding system. (1986) (24)
Childhood Hodgkin's disease: patterns of relapse. (1984) (24)
Protection from radiation nephropathy by WR-2721. (1984) (24)
Radiation Therapy of Benign Diseases: A Clinical Guide (1991) (23)
Rhabdomyosarcoma of head and neck in children. Combination treatment by surgery, irradiation, and chemotherapy. (1973) (23)
Stage I-II pediatric Hodgkin's disease: long-term follow-up demonstrates equivalent survival rates following different management schemes. (1990) (23)
Recent advances in understanding and managing rhabdomyosarcoma (2015) (23)
Combined radiosensitizer infusion and irradiation of osteogenic sarcomas. (1975) (22)
Cystic Hygroma, Lymphangioma (2003) (22)
Incidence and management of secondary malignancies in patients with retinoblastoma and Ewing's sarcoma. (1991) (22)
Factors that influence treatment decisions in childhood rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Group of the Children's Cancer Group, the Pediatric Oncology Group, and the Intergroup Rhabdomyosarcoma Study Group Statistical Center. (1997) (22)
Survival and neurocognitive outcomes after cranial or craniospinal irradiation plus total-body irradiation before stem cell transplantation in pediatric leukemia patients with central nervous system involvement. (2014) (22)
The Outcome of Patients With Localized Undifferentiated Pleomorphic Sarcoma of the Lower Extremity Treated at Stanford University (2019) (22)
Soft-Tissue Sarcomas of the Diaphragm: A Report From the Intergroup Rhabdomyosarcoma Study Group From 1972 to 1997 (2000) (21)
Cost effectiveness and outcome assessment of magnetic resonance imaging in diagnosing cord compression (1995) (21)
Pediatric Hodgkin's disease--up, up, and beyond. (2002) (20)
Cranial nerve involvement in children with leukemia and lymphoma. (1983) (20)
Acute nonlymphocytic leukemia developing during the course of Ewing's sarcoma. (1984) (20)
Effects of therapy on nutritional status of the pediatric cancer patient. (1982) (20)
Safety of intravenous hyperalimentation in children with malignancies: a cooperative group trial. (1982) (19)
Improved outcomes after autologous bone marrow transplantation for children with relapsed or refractory Hodgkin lymphoma: twenty years experience at a single institution. (2015) (19)
Protective effect of hyperthermia against the cytotoxicity of actinomycin D on Chinese hamster cells. (1978) (19)
Outcomes for pediatric patients with osteosarcoma treated with palliative radiotherapy (2020) (19)
Prognostic features of ewing sarcoma on plain radiograph and computed tomography scan after initial treatment. A pediatric oncology group study (8346) (1993) (18)
Hodgkin's disease in children. (1990) (18)
Risk‐based treatment for patients with first relapse or progression of rhabdomyosarcoma: A report from the Children's Oncology Group (2019) (18)
Survival impact of postoperative radiotherapy timing in pediatric and adolescent medulloblastoma (2018) (18)
Local therapy for rhabdomyosarcoma of the hands and feet: is amputation necessary? A report from the Children's Oncology Group. (2011) (18)
Combination radiation-adriamycin therapy: renoprival growth, functional and structural effects in the immature mouse. (1980) (17)
Hypercalcemia and vitamin d metabolism in Hodgkin's disease. Is there an underlying immunoregulatory relationship? (1990) (17)
Treatment results for patients with localized, completely resected (Group I) alveolar rhabdomyosarcoma on Intergroup Rhabdomyosarcoma Study Group (IRSG) protocols III and IV, 1984–1997: A report from the Children's Oncology Group (2010) (17)
Practice patterns and recommendations for pediatric image‐guided radiotherapy: A Children's Oncology Group report (2020) (17)
A rational clinical staging system for childhood rhabdomyosarcoma. (1984) (17)
Combined Enzyme Replacement Therapy and Hematopoietic Stem Cell Transplantation in Mucopolysacharidosis Type VI. (2012) (16)
Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation (2021) (16)
Radiation proctitis after prostate carcinoma therapy. (1994) (16)
Virtual Radiation Oncology Clerkship During the COVID-19 Pandemic and Beyond (2020) (15)
Hodgkin's disease. Treatment of the young child. (1991) (15)
Letter: Adriamycin activating a recall phenomenon after radiation therapy. (1974) (15)
Finding the balance in pediatric Hodgkin's lymphoma. (2012) (14)
Langerhans' cell histiocytosis presenting with the superior vena cava syndrome: a case report. (1993) (14)
Management of the Pregnant Patient with Hodgkinʼs Disease (1982) (14)
Treatment of orbital lymphoid tumors with electron beams. (1991) (14)
Hodgkin's disease: treatment with low dose radiation and chemotherapy. (1981) (14)
An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials (2022) (13)
Partial orbit irradiation achieves excellent outcomes for primary orbital lymphoma. (2016) (13)
Prognostic factors in pediatric Hodgkin’s disease (2001) (12)
Minimizing and measuring lens dose when giving cranial irradiation. (1986) (12)
Randomized phase II window study of two schedules of irinotecan (CPT-11) and vincristine (VCR) in rhabdomyosarcoma (RMS) at first relapse/disease progression (2008) (12)
A story of continuing success-radiotherapy for Ewing's sarcoma. (1981) (11)
The Use of Interstitial Therapy in Pediatric Malignancies1 (1978) (11)
THE USE OF THE GOAT AS AN EXPERIMENTAL ANIMAL. (1964) (11)
Age-related Toxicity in Patients With Rhabdomyosarcoma: A Report From the Children’s Oncology Group (2014) (11)
A discourse: the 2002 Wataru W. Sutow lecture. Hodgkin disease in children--perspectives and progress. (2003) (11)
Hyperfractionated radiotherapy in the management of diffuse intrinsic brainstem tumors: when is enough enough? (1999) (11)
Initial clinical outcomes of audiovisual-assisted therapeutic ambience in radiation therapy (AVATAR). (2017) (11)
Prognostic features of ewing's sarcoma on plain radiograph and computed tomography scan after initial treatment (1994) (11)
Pediatric hodgkin's disease. II. Results of therapy. (1976) (11)
Clinical investigations of children with Hodgkin's disease at Stanford University Medical Center. A preliminary overview using low-dose irradiation and alternating ABVD/MOPP chemotherapy. (1989) (10)
Hemangiomas of infancy: results of 90Y interstitial therapy: a retrospective study. (1979) (10)
The nutritional effects of cancer and its therapy (1980) (10)
Dactinomycin (A) and vincristine (V) with or without cyclophosphamide (C) and radiation therapy (RT) for newly diagnosed patients with low-risk embryonal/botryoid rhabdomyosarcoma (RMS). An IRS-V report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group (STS COG). (2006) (10)
Management of nodular lymphocyte predominant Hodgkin lymphoma in the modern era. (2015) (9)
Ewing's Sarcoma (1986) (9)
Continuing medical education in radiology: a glimpse of the present and of what lies ahead. (2005) (9)
Risk-based care in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS) (2007) (9)
Subspecialty training and certification for radiation oncology. (2004) (9)
The Parotid Gland is an Underrecognized Organ at Risk for Craniospinal Irradiation (2016) (9)
Making choices in the staging of children with Hodgkin's disease. (1991) (9)
Dynamic probabilistic model for determination of optimal timing of surveillance chest radiography in pediatric Hodgkin disease. (1989) (8)
Allogeneic bone marrow transplant in pediatric patients with high-risk hematopoietic malignancies early in the course of their disease. (1997) (8)
Neuro-ocular damage in pediatric oncology patients: predictor of long-term visual disability or tool for limiting toxicity? (1986) (7)
Prognostic features of Ewing's sarcoma on radionuclide bone scan after initial treatment. (1994) (7)
Second-look operation with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma (RMS): A report from the Children's Oncology Group (COG). (2010) (7)
Pediatric patients. Tolerance levels and effects of treatment. (1989) (7)
Extraskeletal osteosarcoma of the hand: the role of marginal excision and adjuvant radiation therapy (2015) (7)
Reinduction of relapsed acute promyelocytic leukemia with ATRA and low dose antimetabolite‐based chemotherapy (2007) (7)
Prognostic factors and outcome in children with metastatic rhabdomyosarcoma - a report from the intergroup rhabdomyosarcoma study IV (2001) (7)
Results from the IRS IV randomized trial of hyperfractionated radiation in children with rhabdomyosarcoma (2000) (7)
Use of cardiac radiation therapy as bridging therapy to CAR‐T for relapsed pediatric B‐cell acute lymphoblastic leukemia (2020) (7)
Results of a prospective clinical trial for VAMP alone without irradiation for pediatric favorable, early-stage Hodgkin lymphoma patients who achieve an early complete response. (2011) (7)
Resectable Pediatric Nonrhabdomyosarcoma Soft Tissue Sarcoma: Which Patients Benefit from Adjuvant Radiation Therapy and How Much? (2012) (6)
A Prospective Randomized Clinical Trial of Total Parenteral Nutrition in Children with Cancer (1982) (6)
High dose chemotherapy and autologous hematopoietic stem cell transplantation in children with refractory and relapsed Hodgkin's Disease: atopy predicts idiopathic diffuse lung injury syndromes (2000) (6)
190 A medical knowledge based system for the selection of beam orientations in intensity-modulated radiation therapy (IMRT) (1999) (6)
Stanford V chemotherapy and involved field radiotherapy for children and adolescents with unfavorable risk Hodgkin lymphoma: Results of a multi-institutional prospective clinical trial. (2012) (6)
Radiation in pediatric Hodgkin's disease. (1998) (6)
The advantages of three-dimensional conformal radiotherapy for treatment of childhood cancer. (1998) (6)
Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group (2022) (6)
Chemoradiation impairs normal developmental cortical thinning in medulloblastoma (2017) (5)
Radiotherapy for Graves' ophthalmopathy: current treatment recommendations. (2001) (5)
Non-Thyroidal Complications of Graves’ Disease: Perspective On Pathogenesis And Treatment (1987) (5)
Effect of coley's toxins and irradiation on the A. Melanoma #3 tumor in the golden hamster (1968) (5)
New methods for precision radiation therapy exceed biological and clinical knowledge and institutional resources needed for implementation. (2000) (5)
Local control for high-grade Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) assigned to radiation therapy on xxx: A report from the xxx. (2021) (5)
Histologic subtypes of breast cancer following radiotherapy for Hodgkin lymphoma. (2014) (5)
Editorial: Is involved field irradiation alone optimal therapy for a child with Hodgkin's disease? (1984) (5)
Technical and practical considerations in the radiotherapy of children. (1987) (5)
Central Nervous System Relapse After Stem Cell Transplantation in Adolescents and Young Adults with Acute Lymphoblastic Leukemia: A Single-Institution Experience. (2019) (5)
Inverse planning for functional imaging-guided IMRT (2002) (4)
Impact of Audio-Visual Assisted Therapeutic Ambience in Radiotherapy (AVATAR) on Anesthesia Use, Payer Charges, and Treatment Time in Pediatric Patients. (2020) (4)
Effect of nutrition as related to radiation and chemotherapy. (1977) (4)
The power of partnerships: a message for all radiologists. (2014) (4)
Letter: Orbital radiotherapy for the ophthalmopathy of Graves's disease. (1974) (4)
HEPATIC CHEMOTHERAPY BY ARTERIAL AND VENOUS INFUSION. (1964) (4)
Special set-up and treatment techniques for the radiotherapy of pediatric malignancies. (1977) (4)
A glimpse into the history of the contributions of women to American radiotherapy. (1994) (3)
Stereotactic body radiotherapy for pediatric hepatocellular carcinoma with central biliary obstruction (2017) (3)
The Effect of Radiation Therapy Techniques (IMRT vs. 3DCRT) on Outcome in Patients with Intermediate Risk Rhabdomyosarcoma Enrolled in COG D9803: A Report from COG (2010) (3)
Rhabdomyosarcoma (2021) (3)
Secondary breast angiosarcoma and germ line BRCA mutations: discussion of genetic susceptibility (2013) (3)
Low-Dose Radiation Therapy (2 Gy x 2) in the Treatment of Non-Hodgkin Lymphoma of the Ocular Adnexa (2013) (3)
Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groups. (2014) (3)
Understanding the risk of second malignant tumors in children with Hodgkin's disease. (2008) (3)
Magna-field irradiation: a note of caution. (1983) (3)
Orthotopic Liver Transplantation After Stereotactic Body Radiotherapy for Pediatric Hepatocellular Carcinoma with Central Biliary Obstruction and Nodal Involvement (2018) (3)
Ethics in Radiation Oncology and the American Society for Radiation Oncology's Role. (2017) (3)
Pancreatic Fistula and Ascites (2003) (3)
SECOND CANCERS IN LONG-TERM SURVIVORS OF EWINGʼS SARCOMA (1992) (3)
Pediatric radiation oncology--subspecialty training? (1992) (3)
Osteoblastoma/Osteoid Osteoma (2003) (3)
Local control outcomes using stereotactic body radiotherapy or surgical resection for metastatic sarcoma. (2022) (3)
Evaluation of local control strategies in patients with localized Ewing sarcoma of bone: A report from the Children’s Oncology Group. (2012) (3)
Vincristine (V) and irinotecan (CPT): A highly active combination in metastatic rhabdomyosarcoma. A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group (STSCOG) (2005) (3)
Faculty Opinions recommendation of Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude lifetime cohort study. (2014) (3)
Is 45 Gy a Sufficient Radiation Therapy Dose for Unresected Orbital Embryonal Rhabdomyosarcoma? A Report From the Soft Tissue Sarcoma Committee of the Children’s Oncology Group (2016) (2)
Influence of radiation therapy (RT) parameters on outcome in children treated for parameningeal rhabdomyosarcoma in the intergroup rhabdomyosarcoma group trials (2002) (2)
Treatment Approach and Outcomes in Infants With Localized Rhabdomyosarcoma (RMS): Analysis of Children’s Oncology Group (COG) Protocols ARST 0331 and ARST0531 (2018) (2)
INFLUENCE OF NON-COMPLIANCE WITH RADIATION THERAPY PROTOCOL GUIDELINES AND OPERATIVE BED RECURRENCES FOR CHILDREN WITH RHABDOMYOSARCOMA AND MICROSCOPIC RESIDUAL DISEASE: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP (2015) (2)
ALARA: in radiation oncology and diagnostic imaging alike. (2014) (2)
82 Primary radiotherapy is curative for CS IE orbital MALT lymphoma (1997) (2)
High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric hodgkin’s disease: analysis of the stanford university results and prognostic indices (2003) (2)
Treatment and outcomes in classic Hodgkin lymphoma post‐transplant lymphoproliferative disorder in children (2019) (2)
Second malignant neoplasms among survivors of pediatric Hodgkin disease treated with low-dose radiation (15-25.5 Gy) and chemotherapy. (2009) (2)
RE:DOES BLADDER PRESERVATION (AS A SURGICAL PRINCIPLE) LEAD TO RETAINING BLADDER FUNCTION IN BLADDER/PROSTATE RHABDOMYOSARCOMA? RESULTS FROM INTERGROUP RHABDOMYOSARCOMA STUDY IV (2004) (2)
Controversies in radiotherapy for pediatric Hodgkin's lymphoma. (2011) (2)
Von Willebrand factor levels do not predict or diagnose radiation pneumonitis. (1986) (2)
The role of craniospinal radiation in the treatment of intracranial germ cell tumors (2001) (2)
Overview of Childhood Pancreatic Tumors (1982) (2)
Breast Imaging in Women Previously Irradiated for Hodgkin Lymphoma (2016) (2)
Temporal trends in chronic disease among survivors of childhood cancer diagnosed across three decades: A report from the Childhood Cancer Survivor Study (CCSS). (2017) (2)
Practice Patterns of Pediatric Image-Guided Radiotherapy (IGRT): A Children’s Oncology Group Report (2019) (2)
Influence of patient displacement and collimator and gantry angle misalignment on intensity modulated radiation therapy (1998) (2)
RADIOTHERAPY OF GRAVES' OPHTHALMOPATHY. AUTHOR'S REPLY (1992) (2)
Desmoid-Aggressive Fibromatosis (1990) (1)
Long-Term Neurologic and Neurosensory Sequelae in Adult Surv ivors of a Chi ldhood Brain Tumor : Chi ldhood Cancer (2003) (1)
Successful use of frameless stereotactic radiosurgery for treatment of recurrent brain metastases in an 18-month-old child (2019) (1)
Local Therapy for Rhabdomyosarcoma of the Hands and Feet: Is There a Role for Amputation? A Report from the Children's Oncology Group (2009) (1)
Introduction and Historical Background: Pediatric Hodgkin Lymphoma (2007) (1)
Use of Audiovisual Assisted Therapeutic Ambience in Radiotherapy (AVATAR) for Anesthesia Avoidance in a Pediatric Patient With Down Syndrome (2020) (1)
A new level of international collaboration: learning from each other about rhabdomyosarcoma. (1996) (1)
Successful Full-term Pregnancies After High-dose Pelvic Radiotherapy for Ewing Sarcoma: A Case Report (2019) (1)
Does radiotherapy improve the cure rate of children/adolescents with completely resected rhabdomyosarcoma who are also treated with chemotherapy? (1998) (1)
Esophageal disease among childhood cancer survivors—A report from the Childhood Cancer Survivors Study (2021) (1)
Congratulations to the 2009 Editorial Fellows (2009) (1)
The place of radiotherapy in modern paediatric oncology. (1988) (1)
Sequelae, sequelae on the wall, which is the fairest modality of them all? (1996) (1)
In response to Drs. Timmerman and Mendonca (2002) (1)
Parotid Gland as an Organ-at-Risk for Craniospinal Irradiation (2012) (1)
Different In Vivo Effects of Horse and Rabbit Antithymocyte Globulin in Patients with Severe Aplastic Anemia (2011) (1)
A 10-Center Prospective Clinical Trial of the Audio-Visual Assisted Therapeutic Ambience in Radiotherapy (AVATAR) System for Anesthesia Avoidance in Pediatric Patients (2022) (1)
Long-term Outcomes of Diffuse or Recurrent Tenosynovial Giant Cell Tumor Treated with Postoperative External Beam Radiation Therapy. (2022) (1)
Homage to M. Vera Peters, MD. (2015) (1)
A tribute to Malcolm A. Bagshaw--an innovative physician who soared to success. (2012) (1)
Benign Prostate Hypertrophy (2003) (1)
Long-term outcomes among survivors of childhood central nervous system tumors: A report from the childhood cancer survivor study (2008) (1)
Prophylactic radiotherapy in retinoblastoma--is it really new? (1993) (1)
Tribute to Professor Maurice Tubiana. (2014) (1)
Impact of Audio-Visual Assisted Therapeutic Ambience in Radiotherapy (AVATAR) on Anesthesia Use, Cost, and Time in Pediatric Patients (2017) (1)
In response to “radiotherapy of graves' ophthalmopathy” (1992) (1)
Management of Hodgkin's disease in the very young (1992) (1)
Risk of second malignant neoplasms (SMN) 20 years after childhood cancer: The updated experience of the Childhood Cancer Survivor Study (CCSS). (2004) (1)
Reported missing founding member of the International Society of Paediatric Oncology …found (2017) (1)
Risk of stroke among > 5 year survivors of childhood leukemia and brain tumors; a report from the Childhood Cancer Survivor Study (2005) (1)
Graves’ Ophthalmopathy - or - Hyperthyroid Ophthalmopathy (2003) (1)
The expanded future of pediatric radiation oncology (2006) (0)
Hypersalivation in Amyotrophic Lateral Sclerosis (2003) (0)
Optic Nerve Glioma (1990) (0)
Excellent Outcome for Pediatric Patients with High Risk Hodgkin Lymphoma with Brentuximab Vedotin and Risk Adapted Residual Node Radiation (2020) (0)
Effect of Testicular Boost in Children With Leukemia Receiving Total Body Irradiation and Stem Cell Transplant: A Single-Institution Experience (2022) (0)
Thalassemic Extramedullary Hematopoiesis with Spinal Cord Compression and Arthropathy (2003) (0)
Dupuytren’s Contracture (2003) (0)
Rapid resolution of orbital pseudotumor treatment by orbital radiotherapy (1978) (0)
Gynecomastia (Prostate Cancer Managed with DES) (2003) (0)
Comment on: Metastatic rhabdomyosarcoma: Evidence of the impact of radiotherapy on survival. A retrospective single‐center experience (2022) (0)
Treatment o f L ocalized N onorbital, N onparameningeal H ead and N eck R habdomyosarcoma : L essons L earned F rom Intergroup R habdomyosarcoma S tudies I II a nd I V (2003) (0)
Effect of hypothalamic/pituitary radiation exposure in low doses on fertility in female childhood cancer survivor study (CCSS) participants. (2010) (0)
Letter to the editor in response to Drs. Constine, Marcus, and Halperin, IJROBP 32:1245–1249; 1995 (1995) (0)
Complications of Treatment in Pituitary Tumors (2003) (0)
Current management and controversies (1989) (0)
Fertility of females after treatment for childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS) (2007) (0)
Intergroup R habdomyosarcoma S tudy-IV: R esults f or Patients W ith N onmetastatic D isease (2001) (0)
Fibrosclerosis Sclerosing -Cervicitis -Retroperitonitis -Mediastinitis -Cholangitis Riedel’s thyroiditis (2003) (0)
Effects of Irradiation and Hematopoetic Stem Cell Transplantation on Airway Hyperreactivity (2007) (0)
Lymphoepithelial Parotid Cysts (2003) (0)
Growth, functional and structural effects of actinomycin-d, vincristine and radiation in the immature mouse kidney (1979) (0)
Survival and Neurocognitive Outcomes Following Addition of a Cranial or Craniospinal Boost to Total Body Irradiation Prior to Stem Cell Transplantation in Pediatric Leukemia Patients With CNS Involvement (2013) (0)
Is involved field irradiation alone optimal therapy for a child with Hodgkin's disease? (1984) (0)
Outcome for Clinical Group III Rhabdomyosarcoma Patients Who Did Not Receive Radiotherapy on IRS-III and -IV (2005) (0)
Tolosa-Hunt Syndrome (2003) (0)
Immunosuppression, Lupus Nephritis, Multiple Sclerosis, and Organ Transplantation (1990) (0)
Giant Cell Tumor (1990) (0)
Prognostic F actors a nd C linical O utcomes i n C hildren a nd Adolescents W ith M etastatic R habdomyosarcoma —A R eport From t he I ntergroup R habdomyosarcoma S tudy I V (2003) (0)
17 Significance and management of computed tomography-detected pulmonary metastases in Wilms' Tumor: A report from the third and fourth national Wilms' Tumor studies (1997) (0)
Significance of Indeterminate Pulmonary Nodules Identified on Chest Computed-tomography in Adult Patients with Newly Diagnosed Sarcoma (2011) (0)
Pregnancy O utcome o f P artners o f M ale S urvivors o f Childhood C ancer: A R eport F rom t he C hildhood C ancer Survivor S tudy (2003) (0)
Long-Term N eurologic a nd N eurosensory S equelae i n A dult Survivors o f a C hildhood B rain T umor: C hildhood C ancer Survivor S tudy (2003) (0)
Predicting Neuropsychological Late Effects in Medulloblastoma With Post Radiation Hippocampal Volume (2015) (0)
Congratulations to the 2008 Editorial Fellows (2008) (0)
Arterial Stenosis and Restenosis (2003) (0)
Faculty Opinions recommendation of Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group. (2011) (0)
Standard of Care (2003) (0)
Congratulations to the 2007 Editorial Fellows (2007) (0)
Faculty Opinions recommendation of Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia. (2013) (0)
Congratulations to the 2008 Editorial Fellows1 (2008) (0)
Risk group accurately predicts outcome in primary extremity non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) in patients <30 years of age: Findings from Children’s Oncology Group study ARST0332. (2018) (0)
Lymphoid Granuloma, Lymphomatoid Granulomatosis (2003) (0)
MB-11IMPACT OF MOLECULAR SUB-TYPE AND CRANIOSPINAL IRRADIATION (CSI) DOSE ON RELAPSE OF MEDULLOBLASTOMA (2015) (0)
Myasthenia Gravis and Thymus Gland Abnormalities (2003) (0)
Impact of Hematopoietic Cell Transplantation with Total Body Irradiation on the Health Status of Childhood Leukemia Survivors: A Report from the Childhood Cancer Survivor Study (CCSS). (2005) (0)
Lethal Midline Granuloma - Wegener’s Granulomatosis, Polymorphic Reticulosis, Lymphomatoid Granulomatosis,Steward’s Disease (2003) (0)
Bursitis, Synovitis and Tendinitis (2003) (0)
Inflammatory Conditions: Arachnoiditis, Tendinitis, Sinusitis, Thyroiditis (2003) (0)
Henry Kaplan and the Story of Hodgkin's Disease, Charlotte DeCroes Jacobs. Stanford University Press (2010), 456 pp (2010) (0)
Larry Emanuel Kun, March 10, 1946-May 27, 2018. (2019) (0)
The radiographic evaluation of 105 consecutive children with Hodgkin's disease. (1976) (0)
Increased sensitivity to 5-fluorouracil in patients with adrenal insufficiency. (1966) (0)
Preservation of ovarian function after lateral ovarian transposition. (1993) (0)
Safety and efficacy of tirapazamine (TPZ) combined with cyclophosphamide (C) and doxorubicin (D) in rhabdomyosarcoma (RMS) at first relapse/disease progression (2008) (0)
Moody D. Wharam Jr, MD, FACR, FASTRO, July 22, 1941-August 10, 2018. (2019) (0)
Abstract of ASTRO scientific paper to be presentedNasopharyngeal carcinoma in the young — a combined M.D. Anderson and Stanford experience (1989) (0)
Lymphoid Hyperplasia - Pseudotumor of the Orbit, Castleman’s Disease (2003) (0)
Feasibility of the Audio-Visual Assisted Therapeutic Ambience in Radiotherapy (AVATAR) system for anesthesia avoidance in pediatric patients: A multicenter trial. (2023) (0)
3001 The internet radiation oncology journal club — A multi-institutional collaborative education project (1997) (0)
Aneurysmal Bone Cysts (2003) (0)
Conformal radiotherapy and paediatric tumours (1999) (0)
Pulmonary, Cardiac and Thyroid Function Following Combined Modality Therapy in Pediatric Hodgkin's Disease (1987) (0)
A comparison of local control achieved by surgery and radiotherapy in patients with non-metastatic pelvic Ewing sarcoma enrolled on INT-0091 (2004) (0)
Paraganglioma(Chromaffin Positive): Chromaffin Negative - see Chemodectoma (2003) (0)
Impact of Testicular Boost on Oncologic Outcomes and Late Effects in Pediatric Patients With Leukemia Receiving Fractionated Total Body Irradiation (TBI): A Single-Institution Experience. (2021) (0)
End Results of a Prospective Clinical Trial with VAMP and Low-Dose, Involved-Field Radiation for Pediatric Patients with Favorable, Early-Stage Hodgkin’s Disease (2005) (0)
l Clinical Original Contribution PARAMENINGEAL RHABDOMYOSARCOMA: RESULTS OF AN INTERNATIONAL WORKSHOP (1996) (0)
History of american women in radiation therapy (1993) (0)
Plasma Cell Granuloma (2003) (0)
Sequelae of Radiation Therapy (2003) (0)
Angiofibroma of the Nasopharynx, Juvenile Nasopharyngeal Angiofibroma (2003) (0)
Collagen Vascular Disorders (2003) (0)
Paraneoplastic Neurologic Symptoms in a Pediatric Patient with Hodgkin Lymphoma (2020) (0)
Erythroplasia of Queyrat (2003) (0)
Heterotopic Bone Formation (2003) (0)
P-417 Malignant pleural mesothelioma; new intrapleural adjuvantstrategies during pleuropneumonectomy; in vitro study (2005) (0)
Extramammary Paget’s Disease (2003) (0)
Jeffrey S. Klein, MD, named editor of RadioGraphics. (2011) (0)
Jeffrey S. Klein, MD, Named Editor of RadioGraphics (2011) (0)
Carbuncles and Furuncles (2003) (0)
Aneuploidy in Benign Tumors and Conditions (2003) (0)
Time to Resolution of Iodine 123 Metaiodobenzylguanidine (123I-MIBG) Avidity in Neuroblastoma Following Radiation Therapy (2020) (0)
Faculty Opinions recommendation of Tumour volume reduction after neoadjuvant chemotherapy impacts outcome in localised embryonal rhabdomyosarcoma. (2015) (0)
Pediatric hodgkin's disease, non-hodkin's lymphoma, and leukemia (1989) (0)
Survival and Neurocognitive Outcomes Following Cranial or Craniospinal Irradiation Plus Total Body Irradiation Prior to Transplantation in Children with CNS Leukemia (2014) (0)
Radiation nephropathy — protection by WR-2721 in the growing mouse kidney (1981) (0)
In Reply to Dr. Nishida et al. (2011) (0)
Special Communication: Congratulations to the 2007 Editorial Fellows (2004) (0)
Time to resolution of iodine‐123 metaiodobenzylguanidine (123I‐MIBG) avidity and local control outcomes for high‐risk neuroblastoma following radiation therapy (2022) (0)
Long-Term Follow-up Results of Advanced or Multiply Recurrent Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor Following External Beam Radiation Therapy (2020) (0)
Salivary Gland Adenoma (1990) (0)
Multidisciplinary management of newly diagnosed pediatric large cell neuroendocrine carcinoma of the lung causing hemoptysis (2021) (0)
RADIOLOGICAL SOCIETY OF NORTH AMERICA, INC: Proposed Amendments to the RSNA Bylaws November, 2017. (2017) (0)
Gorham’s Massive Osteolysis (Spontaneous Absorption of Bone,Phantom Bone) (2003) (0)
Lethal Midline Granuloma (1990) (0)
Astrocytoma (Grade I-II) (2003) (0)
Faculty Opinions recommendation of Favorable outcomes of pediatric patients treated with radiotherapy to the central nervous system who develop radiation-induced meningiomas. (2011) (0)
Multimodality treatment including whole pleura radiation therapy for DICER1‐associated pediatric pleuropulmonary blastoma (2021) (0)
What is the role of involved field radiation among children with localized Non-Hodgkin's lymphoma? (1986) (0)
Outcomes for Pediatric Osteosarcoma Patients Treated with Palliative Radiation Therapy (2018) (0)
Local/regional failure in patients with rhabdomyosarcoma (rms) and microscopic residual disease (2001) (0)
Adenomas of the Parotid(Salivary Gland Adenomas) (2003) (0)
Faculty Opinions recommendation of Visual outcomes in pediatric optic pathway glioma after conformal radiation therapy. (2012) (0)
histopathological study . irradiation for retinoblastoma : a Posterior ocular abnormalities after (0)
Radiation Port Dermatophytosis (2003) (0)
Impact of Molecular Subtype and Craniospinal Irradiation (CSI) Dose on Relapse of Medulloblastoma (2014) (0)
14 A multi-disciplinary study investigating radiotherapy in Ewing's Sarcoma — A final report of pog 8346 (1997) (0)
GROWTH, FUNCTIONAL AND STRUCTURAL EFFECTS OF ACTINOMYCIN-D, VINCRISTINE, ADRIAMYCIN AND RADIATION IN THE IMMATURE MOUSE KIDNEY (1980) (0)
Parameningeal rhabdomyosarcoma: results of an international workshop on irradiation (1994) (0)
Is hyperfractionated radiation plus chemotherapy feasible and tolerable in children with rhabdomyosarcoma (1994) (0)
Congratulations to the 2010 Editorial Fellows (2010) (0)
Analysis Concept Proposal Title: Incidence of chronic disease among childhood cancer survivors by treatment era and temporal trends in treatment exposure Working Group & Investigators: Chronic Disease Working Group (Secondary: Epi/Biostats) (2016) (0)
Sarcoma REGIONAL NODAL INVOLVEMENT AND PATTERNS OF SPREAD ALONG IN-TRANSIT PATHWAYS IN CHILDREN WITH RHABDOMYOSARCOMA OF THE EXTREMITY : A REPORT FROM THE CHILDREN ’ S ONCOLOGY GROUP (2011) (0)
2240 Malignant rhabdoid tumor of the central nervous system: Clinical features, prognostic factors, and treatment efficacy (1999) (0)
2013 RSNA Outstanding Researcher (2014) (0)
Bowen’s Disease (1990) (0)
Role of Radiation Therapy in Non-Hodgkin’s Lymphoma in the Child (1994) (0)
Reply to Second malignancies in Ewing sarcoma survivors (2017) (0)
Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL): Management in the Modern Era (2014) (0)
The Treatment of Cancer by (2016) (0)
879 NEUROBLASTOMA IN INFANTS: WHEN IS THERAPY NECESSARY? (1985) (0)
Chemodectomas (Non-Chromaffin Paragangliomas, GlomusJugulare, Carotid Body Tumors) (2003) (0)
Clarification regarding radiation-induced height impairment in pediatric Hodgkin's disease. (1995) (0)
Prognostic F actors f or C hildren W ith H odgkin's D isease Treated W ith C ombined-Modalit y T herapy (2003) (0)
Current management and controversies. A radiotherapist's view. (1989) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Sarah S. Donaldson?

Sarah S. Donaldson is affiliated with the following schools:

Washington University in St. Louis
University at Buffalo
University of Oregon
Stanford University
University of Washington
University of California, San Francisco
University of Nebraska Medical Center
Harvard University